Abbott Labs Swings to Loss After Booking Charge on Mylan Stake

Abbott Laboratories swung to a loss in the most recent quarter as it booked a hefty charge related to the stock-price drop of embattled EpiPen maker Mylan NV, in which it owns a stake.

from WSJ.com: US Business http://ift.tt/2e7FLl7
via IFTTT